Patents by Inventor Hiromichi Ishikawa

Hiromichi Ishikawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250100078
    Abstract: A build system includes: a build apparatus that is configured to irradiate an object with an energy beam from a position above the object and that is configured to build a build object on the object by supplying a build material to an irradiation position of the energy beam; a support apparatus that includes three or more support members for supporting the object; and a heating apparatus configured to heat the object from a position under the object, each support member includes: a connecting part that contacts the object; and a support part configured to support the object, a stiffness of the support part in a first direction is lower than a stiffness of the support part in a second direction that intersects the first direction, the second direction is a direction that intersects a plane including the connecting parts of the three or more support members.
    Type: Application
    Filed: January 19, 2022
    Publication date: March 27, 2025
    Applicant: NIKON CORPORATION
    Inventors: Hiromichi MURATA, Takayuki FUNATSU, Motofusa ISHIKAWA
  • Patent number: 12218403
    Abstract: It is an object to provide an antenna that improves wireless communication with a plurality of communication devices disposed at different locations. The antenna includes an antenna body, a case including a bottom surface and side surfaces disposed around the bottom surface, the case supporting the antenna body on the bottom surface, the case being formed of metal, and a ceiling portion disposed in such a manner to face the bottom surface of the case, the ceiling portion being in contact with the side surfaces, the ceiling portion being formed of a dielectric body, and a distance between the ceiling portion and the antenna body is shorter than a half of a wavelength of a predetermined frequency serving as a frequency to be used.
    Type: Grant
    Filed: February 19, 2021
    Date of Patent: February 4, 2025
    Assignee: KYOCERA CORPORATION
    Inventors: Hiromichi Yoshikawa, Satoshi Ishikawa
  • Publication number: 20250018772
    Abstract: A drainage structure for an air-conditioning device of a vehicle, the vehicle includes: a partition wall configured to partition between an interior and an exterior of a vehicle cabin for a passenger; an evaporator arranged at an outside of the partition wall for the vehicle cabin, the evaporator being configured to cool the air to be supplied to the interior of the vehicle cabin through the heat exchange with the refrigerant; and a cover attached to the partition wall from the front side of the vehicle cabin, the cover being configured to accommodate the evaporator. The drainage structure includes a drain pipe for draining the condensed water generated by the evaporator to the outside by extending in the attachment direction of the cover by being inserted into the cover, wherein the drain pipe has the slit formed so as to be inclined upwards along the extending direction from the lower end portion.
    Type: Application
    Filed: November 2, 2022
    Publication date: January 16, 2025
    Applicant: Highly Marelli Japan Corporation
    Inventors: Makoto AOSHIKA, Takahito ISHIKAWA, Hiromichi YANASHIMA, Ryuuji TSUKUDA
  • Patent number: 6645179
    Abstract: An injection syringe generally comprised of a multichambered cylindrical ampule, a tripartite case of a front case; a middle case; a rear case, and a needle-holder, and a plunger: the multichambered cylindrical ampule including two chambers of a front space and a rear space, the front space being sealed forwardly with a packing penetrable by a needle and sealed rearwardly with a movable front gasket, and the rear space being sealed forwardly with the front gasket and sealed rearwardly with a movable rear gasket, and the ampule also including a bypass route longitudinally arranged on inner surface of the ampule such that the front gasket is located to take a position rearwardly apart from the bypass route before dissolution of a solid medicine, wherein the front space for admission of the solid medicine is separated from the rear space for admission of a medicinal solvent or dispersing agent; the middle case also including a short thread or fixer means provided externally at midportion thereof, and the rear ca
    Type: Grant
    Filed: July 6, 2000
    Date of Patent: November 11, 2003
    Assignee: Nihon Chemical Research Co., Ltd.
    Inventors: Hiromichi Ishikawa, Shinichi Koni
  • Patent number: 6319225
    Abstract: An injection syringe including a device for preparation of an injection in situ, useful to the injection which is liable to suffer chemical changes if left for a long time in the state of solution or dispersion ready to inject. The injection syringe is portable by a patient who may prepare a necessary injection in situ with the use of a device included in the syringe which will automatically perform an injection with a prescribed dosage. The injection syringe includes a device for preparation of an injection, whereby mechanical impacts affecting the medicine and consequently, chemical changes with a medicine would be minimized during the step of dissolving the medicine. The syringe as noted is especially useful for preparation of injection and injection of human growth hormones, interferon and various polypeptides which are of an environmentally sensitive nature and liable to suffer chemical changes if left for a long time in the state of solution or dispersion.
    Type: Grant
    Filed: March 12, 1999
    Date of Patent: November 20, 2001
    Assignee: Nihon Chemical Research Co., Ltd.
    Inventors: Koichi Sugita, Sei Kirihara, Hiromichi Ishikawa, Yutaka Igarashi
  • Patent number: 5985924
    Abstract: The present invention provides novel metastasis suppressory agents with a lowered degree of toxicity, comprising ursolic acid or its salt as an active ingredient, which can be administered to patients per os or through injection, thus enabling the patients to receive post-operative ambulatory treatment.
    Type: Grant
    Filed: November 15, 1996
    Date of Patent: November 16, 1999
    Assignee: JCR Pharmaceuticals Co., Ltd.
    Inventors: Hiromichi Ishikawa, Tomoko Watanabe, Satoshi Nishimuro, Mitsuru Hirota
  • Patent number: 5948752
    Abstract: According to the present invention, there are provided suppressory agents against hypercoagulation which comprise as an effective ingredient protein C inhibitor with a molecular weight of 54 to 57 kDa (DS-PAGE) being capable of suppressing function of the blood coagulation system.
    Type: Grant
    Filed: August 11, 1998
    Date of Patent: September 7, 1999
    Assignee: JCR Pharmaceuticals Co., Ltd.
    Inventors: Mitsugu Fujita, Yoshikazu Komurasaki, Keihide Koh, Hiromichi Ishikawa
  • Patent number: 5781743
    Abstract: In a distributed application program system which includes a data transmission line, a plurality of server systems connected to the data transmission line and each including at least one application program for executing data processing by running the program, and a client system connected to the data transmission line and including at least one application program for executing data processing by running the application program, a method of controlling the distributed application program system is performed. The method includes the steps of preparing a library for storing system specifications of the individual systems in association with one of the plural server systems which is to serve as a master server system, and deciding whether or not a table provided in association with the client system already contains system specifications of the server system to which data processing is to be entrusted.
    Type: Grant
    Filed: February 17, 1995
    Date of Patent: July 14, 1998
    Assignee: Hitachi, Ltd.
    Inventors: Hideki Matsuno, Kazuhiro Katayama, Hiromichi Ishikawa
  • Patent number: 5688818
    Abstract: Provision of a succinamic acid compound of the formula (1) ##STR1## wherein R.sup.1 is an alkyl or a lower alkenyl and R.sup.2 is an optionally esterified carboxyl, a pharmaceutically acceptable salt thereof, an agent for the prophylaxis and/or treatment of the complications of diabetes, comprising, as an active ingredient, the succinamic acid compound or a pharmaceutically acceptable salt thereof, an aldose reductase inhibitor comprising, as an active ingredient, the succinamic acid compound or a pharmaceutically acceptable salt thereof, and a method for producing the succinamic acid compound or a pharmaceutically acceptable salt thereof. The novel succinamic acid compounds of the formula (1) of the present invention and pharmaceutically acceptable salts thereof have a strong aldose reductase activity-inhibitory in mammals such as human, and show superior safety.
    Type: Grant
    Filed: March 14, 1996
    Date of Patent: November 18, 1997
    Assignees: Senju Pharmaceutical Co., Ltd., The Green Cross Corporation
    Inventors: Hiroshi Hosono, Toshiyuki Nishio, Hiromichi Ishikawa, Yoshiyuki Nakamura, Tetsuo Matsui
  • Patent number: 5677300
    Abstract: A pyridothiazineacetic acid compound of the formula (I) ##STR1## wherein each symbol is as defined in the specification, a pharmaceutically acceptable salt thereof, production thereof, and a pharmaceutical composition, an aldose reductase inhibitor and a preparation for the prevention and treatment of the complications of diabetes, containing the same.The pyridothiazineacetic acid compound and a pharmaceutically acceptable salt thereof of the present invention have an aldose reductase inhibitory action and are superior in safety. Accordingly, they are useful as a preparation for the prevention and treatment of the complications of diabetes, such as faulty union of corneal injury, cataract, neurosis, retinopathy and nephropathy, particularly, cataract and neurosis. In addition, the production method of the present invention enables efficient production of said pyridothiazineacetic acid compound.
    Type: Grant
    Filed: September 3, 1996
    Date of Patent: October 14, 1997
    Assignees: The Green Cross Corporation, Senji Pharmaceutical Co., Ltd.
    Inventors: Hiroshi Hosono, Tomoji Aotsuka, Yoshiyuki Nakamura, Tetsuo Matsui, Hiromichi Ishikawa
  • Patent number: 5635505
    Abstract: A 1,4-benzoxazine-2-acetic acid compound of the formula (I) ##STR1## wherein each symbol is as defined in the specification, a pharmaceutically acceptable salt thereof, a method for production thereof, and a pharmaceutical composition, an aldose reductase inhibitor and an agent for the prevention and/or treatment of the complications of diabetes, which contain the same. The compound (I) of the present invention and pharmaceutically acceptable salts thereof have aldose reductase inhibitory action and are superior in safety. Accordingly, they are useful as an agent for the prevention and/or treatment of the complications of diabetes such as faulty union of corneal injury, cataract, neurosis, retinopathy and nephropathy, in particular, cataract and neurosis.
    Type: Grant
    Filed: July 3, 1996
    Date of Patent: June 3, 1997
    Assignees: Senju Pharmaceutical Co., Ltd., The Green Cross Corporation
    Inventors: Takahiro Kumonaka, Takema Hase, Tomoji Aotsuka, Toshio Kurihara, Yoshiyuki Nakamura, Tetsuo Matsui, Hiromichi Ishikawa, Fujio Kobayashi
  • Patent number: 5572724
    Abstract: In a distributed system having a plurality of interconnected computer systems each having an application program, a process manager which determines the need for a communication process, determines an identifier of a destination system and a protocol and issues a communication process request in response to a process request for database access from the application program, and a virtual communication user for determining an application context in response to the communication process request from the process manager are provided, and a communication path a protocol machine establishes for the virtual communication user. A plurality of virtual communication users for managing the communication process are provided and each virtual communication user manages a plurality of protocol machines so that a plurality of protocols and application programs are simultaneously used for a plurality of destination systems from one application program.
    Type: Grant
    Filed: October 12, 1993
    Date of Patent: November 5, 1996
    Assignees: Hitachi, Ltd., Hitachi Seibu Software Co., Ltd.
    Inventors: Tetsuya Watanabe, Hiromichi Ishikawa, Masaaki Hatano
  • Patent number: 5543420
    Abstract: A quinoline-3-acetic acid derivative of the formula ##STR1## wherein R.sup.1, R.sup.2 and R.sup.3 are the same or different and each is a hydrogen atom or a halogen atom, R.sup.4 is a hydrogen atom, a halogen atom or a substituted or unsubstituted lower alkyl, R.sup.5 is an optionally esterified carboxyl and the broken line means an optional presence of a double bond, and a pharmaceutically acceptable salt thereof. The novel compound of the formula (I) and a pharmaceutically acceptable salt thereof of the present invention have an aldose reductase inhibitory activity in mammals inclusive of human and are highly safe. Accordingly, they are useful as pharmaceutical compositions for the treatment of the complications of diabetes, such as faulty union of corneal injury, cataract, neurosis, retinopathy and nephropathy, particularly cataract and neurosis.
    Type: Grant
    Filed: November 1, 1994
    Date of Patent: August 6, 1996
    Assignees: The Green Cross Corporation, Senju Pharmaceutical Co., Ltd.
    Inventors: Tomoji Aotsuka, Toshiyuki Nishio, Hiroshi Hosono, Yoshiyuki Nakamura, Tetsuo Matsui, Hiromichi Ishikawa
  • Patent number: 5532257
    Abstract: Production of a benzothiazole compound of the formula (I) ##STR1## wherein R.sup.1 is a halogen atom, R.sup.2 and R.sup.3 may be the same or different and each is a hydrogen atom or a halogen atom, R.sup.4 is a hydrogen atom, a halogen atom, a lower alkyl, an alkoxy or an alkyl mercapto and R.sup.5 is a hydrogen atom or a lower alkyl, or a pharmaceutically acceptable salt thereof.The compound of the formula (I) and a pharmaceutically acceptable salt thereof of the present invention have an aldose reductase inhibitory activity in mammals inclusive of human and have superior safety. Accordingly, they are useful as pharmaceutical compositions for the treatment of the complications of diabetes, such as faulty union of corneal injury, cataract, neurosis, retinopathy and nephropathy, particularly cataract and neurosis.
    Type: Grant
    Filed: November 25, 1994
    Date of Patent: July 2, 1996
    Assignees: Senju Pharmaceutical Co., Ltd, The Green Cross Corporation
    Inventors: Takema Hase, Takahiro Kumonaka, Chikako Shimizu, Hiroshi Hosono, Tomoji Aotsuka, Yoshiyuki Nakamura, Tetsuo Matsui, Hiromichi Ishikawa
  • Patent number: 5116838
    Abstract: There are disclosed novel 1,3-dibenzyl (or diphenethyl)-2-phenylguanidine derivatives. The guanidines possess high control effects on mildew, blight, powdery mildew and rust which are serious diseases of fruit trees, vegetables or cereals, and are useful as agricultural and horticultural fungicides.
    Type: Grant
    Filed: November 15, 1990
    Date of Patent: May 26, 1992
    Assignee: Hokko Chemical Industry Co., Ltd.
    Inventors: Hiromichi Ishikawa, Takashi Umeda, Shinji Onoue, Kazuo Kajikawa, Toshihiro Shibata, Hiroshi Ohyama
  • Patent number: 5046002
    Abstract: A distributed data base access request processing system in a distributed data base system including a computer system having a data base and a plurality of computer system effecting an update or a reference to the data base. A client side requesting a data base access issues a request for a synchronous processing to a server side if the data base access is related to a reference operation; whereas an asynchronous processing is requested if the data base access is associated with an update operation. On receiving such a request of a synchronous processing, the server side returns a response to the client side after the requested data base processing is completed. If an asynchronous processing is requested, the response is returned to the client side without waiting for the completion of the requested data base processing.
    Type: Grant
    Filed: April 26, 1990
    Date of Patent: September 3, 1991
    Assignee: Hitachi, Ltd.
    Inventors: Rinichi Takashi, Hiromichi Ishikawa
  • Patent number: 4838715
    Abstract: An ink ribbon cassette for supplying ink from an ink-impregnated material to an ink ribbon in which the ink-impregnated material is loaded directly in the cassette body without an ink tank, and in which leakage of ink caused, for instance, by vibration or sudden temperature change, is positively prevented. The ribbon cassette includes a cassette body having a container formed as an integral part thereof and a cover fixedly secured to the cassette body. The container accommodating the ink-impregnated material is formed in such a manner that a space is formed between the ink-impregnated material and the cover, and an ink pool having a capillary action is formed on the inner surface of an outer peripheral wall defining the container.
    Type: Grant
    Filed: February 24, 1988
    Date of Patent: June 13, 1989
    Assignee: Pilot Man-Nen Hitsu Kabushiki Kaisha
    Inventor: Hiromichi Ishikawa
  • Patent number: 4547524
    Abstract: Compounds of the formula ##STR1## wherein R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are as herein defined useful as insecticides, is described.
    Type: Grant
    Filed: February 14, 1983
    Date of Patent: October 15, 1985
    Assignee: Hokko Chemical Industry Co., Ltd.
    Inventors: Kimiyoshi Kaneko, Hiromichi Ishikawa, Satoru Moriyama, Tsugio Uchiyama
  • Patent number: 4443439
    Abstract: New phenylthionophosphonic acid O,O-di-esters of the general formula: ##STR1## wherein R.sub.1 denotes a lower alkyl group; R.sub.2 denotes a hydrogen atom, a lower alkyl group or an unsaturated lower alkyl group; and R.sub.3 denotes a lower alkyl group or an unsaturated lower alkyl group are provided, which have high insecticidal, miticidal and nematocidal activities and are useful as pesticidal agents to be applied to insect, acarine and/or nematode pests.
    Type: Grant
    Filed: August 27, 1982
    Date of Patent: April 17, 1984
    Assignee: Hokko Chemical Industry Co., Ltd.
    Inventors: Hiromichi Ishikawa, Kazuhiko Kitaori, Satoru Moriyama, Tadashi Chono, Tsugio Uchiyama
  • Patent number: 4421750
    Abstract: New organophosphoric acid ester anhydride derivatives, more particularly new thiopyrophosphoric acid P,P,P'-trialkylester-P'-dialkylamide of the formula ##STR1## wherein R.sub.1 is an alkyl group of 3 to 6 carbon atoms and R.sub.2, R.sub.3 and R.sub.4 may be the same or different from each other and each are an alkyl group of 1 to 6 carbon atoms are now provided. These new organophosphoric acid ester anhydride derivatives have high insecticidal, miticidal and nematocidal activities and are useful as an insecticidal, miticidal and nematocidal agent.
    Type: Grant
    Filed: March 2, 1982
    Date of Patent: December 20, 1983
    Assignee: Hokko Chemical Industry Co., Ltd.
    Inventors: Hiromichi Ishikawa, Kazuhiko Kitaori, Kimiyoshi Kaneko, Satoru Moriyama, Takashi Kobayashi, Tsugio Uchiyama